Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema

• Status: Completed
• Trial end date: 2016-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Retrospective cases series is a non-randomized, open-label, single-center investigation (Retina Clinic, São Paulo, Brazil) of patients diagnosed with macular edema secondary to diabetic retinopathy (DME) and retinal vein occlusions who underwent to simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and implant of dexamethasone 0.7mg.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Retina Clinic, Sao Paulo, Brazil
• Treatments: BB 1101; Bevacizumab; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

• central macular thickness > 300 µm on optical coherence tomography (OCT)

• macular edema secondary to diabetic retinopathy (DME) and retinal vein occlusions

Exclusion Criteria:

• intravitreal anti-VEGF within 6 weeks

• treatment with laser or intravitreal corticosteroids within 3 months of study entry.